Downloads
Abstract
Background: Among all the neurological disorders that can most frequently be found in the post COVID-19, headache symptomatology is a possible chronic sequela of the infection, making up a rate of 19% after 3 months and 16% after 9 months. This study aims to asses the effectiveness and safety of the acupuncture therapy for post COVID-19 headache treatment.
Methods: A cross - sectional descriptivestudy was carried out on 40 patients with post COVID-19 headache who were receiving acupuncture treatment at Hue Central Hospital. The primary outcomes were pain VAS (Visual Analog Scale) and HIT-6 (Headache Impact Test). The secondary outcome was adverse therapy reactions.
Results: The pain VAS and HIT-6 declined significantly -3.77 ± 1.46 and -15.97 ± 3.25, respectively. No adverse reactions were found during the study.
Conclusion: Based on the high quality of evidence, we concluded that acupuncture may be an effective and safe therapy for post COVID-19 headache treatment.
References
Membrilla JA, Caronna E, Trigo-López J, González-Matínez A, Layos-Romero A, Pozo-Rosich P, Guerrero-Peral A, et al. Persistent headache after COVID-19: Pathophysiology, clinic and treatment. Neurology Perspectives. 2021; 1: 31-36.
Martelletti P, Bentivegna E, Spuntarelli V, Luciani M. LongCOVID Headache. SN Comprehensive Clinical Medicine. 2021; 3(8):1704–1706.
World Health Organization. Coronavirus disease (COVID-19): Post COVID-19 condition, 2021. Available at https://www.who.int/news-room/questions-and-answers/ item/coronavirus-disease-(covid-19)-post-covid-19- condition. Accessed 16 December 2021.
Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, González-Matínez A, et al. PostCOVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients. Cephalalgia. 2022; 42(8): 804-809.
Krymchantowski AV, Silva-Néto RP, Jevoux C, Krymchantowski AG. Indomethacin for refractory COVID or post-COVID headache: a retrospective study. Acta Neurol Belg. 2022; 122(2): 465-469.
Li Y, Xiao X, Zhong D, Luo L, Yang H, Zhou J, et al. Effectiveness and Safety of Acupuncture for Migraine: An Overview of Systematic Reviews. Pain Research and Management. 2020; 2020: 3825617.
Nachit-Ouinekh F, Dartigues J, Henry P, Becg J, Chastan G, Lemaireb N, et al. Use of the headache impact test (HIT-6) in general practice: relationship with quality of life and severity. European Journal of Neurology. 2005; 12: 189-193.
Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. 2021. A Review of Persistent Post COVID Syndrome (PPCS). Clinical Reviews in Allergy & Immunology. 2021; 1-9.
Pavli A, Theodoridou M, Maltezou HC. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Archives of Medical Research. 2021; 52(6):575-581.
| Published | 26-12-2024 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 92 (2023) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.92.13 | |
| Keywords | Post COVID-19 condition, Post COVID-19 headache, Acupuncture. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Journal of Clinical Medicine Hue Central Hospital